EXACT Sciences Corporation (EXAS) is around the bottom of the Diagnostics & Research industry according to InvestorsObserver. EXAS received an overall rating of 34, which means that it scores higher than 34 percent of all stocks. EXACT Sciences Corporation also achieved a score of 29 in the Diagnostics & Research industry, putting it above 29 percent of Diagnostics & Research stocks. Diagnostics & Research is ranked 41 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 34 means the stock is more attractive than 34 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With EXACT Sciences Corporation Stock Today?
EXACT Sciences Corporation (EXAS) stock has gained 2.27% while the S&P 500 is lower by -0.55% as of 2:14 PM on Tuesday, Sep 29. EXAS is higher by $2.26 from the previous closing price of $99.70 on volume of 1,658,061 shares. Over the past year the S&P 500 is higher by 11.98% while EXAS is higher by 12.83%. EXAS lost -$1.04 per share the over the last 12 months.
Click Here to get the full Stock Score Report on EXACT Sciences Corporation (EXAS) Stock.